BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Adhoute X, Pénaranda G, Raoul JL, Bourlière M. Usefulness of the MESH score in a European hepatocellular carcinoma cohort. World J Hepatol 2017; 9(15): 711-714 [PMID: 28596819 DOI: 10.4254/wjh.v9.i15.711]
URL: https://www.wjgnet.com/1948-5182/full/v9/i15/711.htm
Number Citing Articles
Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, Marc Bourlière. Intermediate stage treatment: Is TACE enough?Liver International 2018; 38(1): 187 doi: 10.1111/liv.13598
Sophia Heinrich, Martin Sprinzl, Irene Schmidtmann, Elena Heil, Sandra Koch, Carolin Czauderna, Bernd Heinrich, Laurence Philippe P Diggs, Marcus‐Alexander Wörns, Roman Kloeckner, Peter R Galle, Jens U Marquardt, Arndt Weinmann. Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patientsUnited European Gastroenterology Journal 2020; 8(4): 444 doi: 10.1177/2050640620904524
Giovanni Marasco, Franco Trevisani. Time to move beyond the classical prognostic systems for patients with advanced hepatocellular carcinoma undergoing SorafenibDigestive and Liver Disease 2021; 53(9): 1210 doi: 10.1016/j.dld.2021.04.037
Xavier Adhoute, Guillaume Penaranda, Jean‐Luc Raoul, Marc Bourlière. Prediction of benefit after transarterial chemoembolization (TACE): Subclassifications or scoring systems?Liver International 2018; 38(1): 184 doi: 10.1111/liv.13516